Literature DB >> 11532323

A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide.

H Lee1, J H Jeong, T G Park.   

Abstract

A fusogenic peptide, KALA, was conjugated with poly(ethylene glycol) (PEG) for use as an endosome disruptive agent in the gene delivery formulation of polyethyleneimine (PEI). A maleimide terminated methoxy-PEG, a cysteine specific derivative, was reacted with KALA to produce a PEG-KALA conjugate. The conjugate was analyzed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, and its hemolytic activity was determined relative to KALA. Positively charged PEG-KALA conjugate was coated onto the surface of negatively charged DNA/PEI complexes to form net positively charged PEG-KALA/DNA/PEI complexes. They were 200-400 nm in diameter with increasing amount of PEG-KALA, whereas DNA/PEI complexes coated with KALA aggregated to a great extent. This was because PEG chains surrounding the surface of the complexes suppressed the inter-particle interaction that was mediated by cationic KALA. Transfection efficiency progressively increased as the amount of PEG-KALA to be coated was increased, suggesting that fusogenic activity of KALA contributes to enhancing the level of gene expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532323     DOI: 10.1016/s0168-3659(01)00426-6

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  18 in total

1.  In vitro gene transfection in human glioma cells using a novel and less cytotoxic artificial lipoprotein delivery system.

Authors:  Guangliang Pan; Mohannad Shawer; Svein Oie; D Robert Lu
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

2.  Synthetic PEGylated glycoproteins and their utility in gene delivery.

Authors:  Chang-po Chen; Ji-seon Kim; Dijie Liu; Garrett R Rettig; Marie A McAnuff; Molly E Martin; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2007 Mar-Apr       Impact factor: 4.774

3.  Nanomedicine for gene therapy.

Authors:  Susan Muthe Alex; Chandra P Sharma
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

4.  Effect of serum on transfection by polyethylenimine/virus-like particle hybrid gene delivery vectors.

Authors:  David M Drake; Rahul K Keswani; Daniel W Pack
Journal:  Pharm Res       Date:  2010-08-21       Impact factor: 4.200

Review 5.  Functional peptides for siRNA delivery.

Authors:  Wanyi Tai; Xiaohu Gao
Journal:  Adv Drug Deliv Rev       Date:  2016-08-13       Impact factor: 15.470

6.  Efficient intracellular gene delivery using the formulation composed of poly (L-glutamic acid) grafted polyethylenimine and histone.

Authors:  Jingjing Deng; Yuting Wen; Cuifeng Wang; Shirong Pan; Huaiyu Gu; Xin Zeng; Lina Han; Yuefang Zhao; Min Feng; Chuanbin Wu
Journal:  Pharm Res       Date:  2010-12-14       Impact factor: 4.200

7.  Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo.

Authors:  Christopher E Nelson; James R Kintzing; Ann Hanna; Joshua M Shannon; Mukesh K Gupta; Craig L Duvall
Journal:  ACS Nano       Date:  2013-09-23       Impact factor: 15.881

Review 8.  Application of advances in endocytosis and membrane trafficking to drug delivery.

Authors:  Yaping Ju; Hao Guo; Maria Edman; Sarah F Hamm-Alvarez
Journal:  Adv Drug Deliv Rev       Date:  2020-08-03       Impact factor: 15.470

9.  Development of a targeted siRNA delivery system using FOL-PEG-PEI conjugate.

Authors:  Bijesh K Biswal; Niladri B Debata; Rama S Verma
Journal:  Mol Biol Rep       Date:  2009-10-09       Impact factor: 2.316

10.  Polyethylenimine-mediated gene delivery to the lung and therapeutic applications.

Authors:  Sante Di Gioia; Massimo Conese
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.